-
PSTX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Poseida Therapeutics (PSTX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 49.34 mm | 49.34 mm | 49.34 mm | 49.34 mm | 49.34 mm | 49.34 mm |
Cash burn (monthly) | (no burn) | (no burn) | (no burn) | 5.16 mm | 3.20 mm | 1.25 mm |
Cash used (since last report) | n/a | n/a | n/a | 20.78 mm | 12.87 mm | 5.04 mm |
Cash remaining | n/a | n/a | n/a | 28.56 mm | 36.47 mm | 44.30 mm |
Runway (months of cash) | n/a | n/a | n/a | 5.5 | 11.4 | 35.4 |
13F holders | Current |
---|---|
Total holders | 98 |
Opened positions | 18 |
Closed positions | 13 |
Increased positions | 35 |
Reduced positions | 21 |
13F shares | Current |
---|---|
Total value | 149.92 bn |
Total shares | 62.70 mm |
Total puts | 22.20 k |
Total calls | 377.20 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
FMR | 14.57 mm | $41.67 bn |
Malin Life Sciences | 9.19 mm | $119.54 mm |
Pentwater Capital Management | 5.98 mm | $17.09 bn |
BlackRock | 5.12 mm | $14.65 bn |
Silverarc Capital Management | 3.69 mm | $10.55 bn |
Vanguard | 3.66 mm | $10.48 bn |
Millennium Management | 2.19 mm | $6.27 bn |
Boxer Capital | 2.00 mm | $5.72 bn |
STT State Street | 1.71 mm | $4.89 bn |
Geode Capital Management | 1.62 mm | $4.63 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Jan 25 | Gergen Mark J | Common Stock | Dispose U | No | No | 0 | 636,726 | 0.00 | 0 | |
8 Jan 25 | Gergen Mark J | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.38 | 172,600 | 583.39 k | 0 |
8 Jan 25 | Gergen Mark J | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.35 | 364,060 | 1.95 mm | 0 |
8 Jan 25 | Gergen Mark J | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.75 | 518,500 | 2.46 mm | 0 |
8 Jan 25 | Gergen Mark J | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 9.15 | 342,000 | 3.13 mm | 0 |
8 Jan 25 | Gergen Mark J | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 16 | 75,000 | 1.20 mm | 0 |
8 Jan 25 | Gergen Mark J | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 12.23 | 48,115 | 588.45 k | 0 |
8 Jan 25 | Gergen Mark J | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.78 | 240,721 | 669.20 k | 0 |
8 Jan 25 | Charles M Baum | Common Stock | Dispose U | No | No | 0 | 78,600 | 0.00 | 0 | |
8 Jan 25 | Charles M Baum | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.81 | 27,350 | 76.85 k | 0 |